{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:50:58Z","timestamp":1781941858279,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004854","name":"St Antonius Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jtha.2025.11.005","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:41:23Z","timestamp":1764808883000},"page":"1263-1278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of continuation versus interruption of oral anticoagulation during transcatheter aortic valve implantation on hemostasis function"],"prefix":"10.1016","volume":"24","author":[{"given":"Dirk Jan","family":"van Ginkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Stragier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem L.","family":"Bor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Rosseel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke","family":"Konings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Ninivaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"de Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Huskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Roest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"van Lenthe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Overduin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol W.","family":"Aarnink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim J.P.","family":"Rooijakkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Peper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorn","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent J.","family":"Nijenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benno J.W. M.","family":"Rensing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Timmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Swaans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris M.","family":"Hackeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"ten Cate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"de Laat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurri\u00ebn M.","family":"ten Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.11.005_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.11.005_bib2","first-page":"e35","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.11.005_bib3","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1016\/j.jcin.2023.10.011","article-title":"Bleeding in patients undergoing transfemoral transcatheter aortic valve replacement: incidence, trends, clinical outcomes, and predictors","volume":"16","author":"van Nieuwkerk","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jtha.2025.11.005_bib4","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s12471-021-01638-8","article-title":"Major threats to early safety after transcatheter aortic valve implantation in a contemporary cohort of real-world patients","volume":"29","author":"van Ginkel","year":"2021","journal-title":"Neth Heart J"},{"key":"10.1016\/j.jtha.2025.11.005_bib5","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jacc.2022.11.050","article-title":"Bleeding events after transcatheter aortic valve replacement: JACC state-of-the-art review","volume":"81","author":"Avvedimento","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.11.005_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007546","article-title":"Predictors, incidence, and outcomes of patients undergoing transfemoral transcatheter aortic valve implantation complicated by stroke","volume":"12","author":"Vlastra","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jtha.2025.11.005_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2022.05.002","article-title":"Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation","volume":"101","author":"van Ginkel","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jtha.2025.11.005_bib8","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jcin.2021.06.020","article-title":"Antithrombotic therapy after transcatheter aortic valve replacement","volume":"14","author":"Capodanno","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jtha.2025.11.005_bib9","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jcin.2023.02.039","article-title":"Sex differences in outcomes after transcatheter aortic valve replacement: a POPular TAVI Subanalysis","volume":"16","author":"van Bergeijk","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jtha.2025.11.005_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jcin.2018.11.008","article-title":"Impact of short-term complications on mortality and quality of life after transcatheter aortic valve replacement","volume":"12","author":"Arnold","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jtha.2025.11.005_bib11","first-page":"1107","article-title":"The impact of stroke and bleeding on mortality and quality of life during the first year after TAVI: a POPular TAVI subanalysis","volume":"104","author":"van Nuland","year":"2024","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jtha.2025.11.005_bib12","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehab196","volume":"42","author":"Ten Berg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.11.005_bib13","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jcin.2015.01.020","article-title":"Incidence and predictors of debris embolizing to the brain during transcatheter aortic valve implantation","volume":"8","author":"Van Mieghem","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jtha.2025.11.005_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.amjcard.2021.01.042","article-title":"Blood coagulation changes with or without direct oral anticoagulant therapy following transcatheter aortic valve implantation","volume":"147","author":"Katayama","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtha.2025.11.005_bib15","doi-asserted-by":"crossref","first-page":"e02","DOI":"10.15420\/icr.2019.24","article-title":"Anticoagulation after transcatheter aortic valve implantation: current status","volume":"15","author":"Greco","year":"2020","journal-title":"Interv Cardiol Rev"},{"key":"10.1016\/j.jtha.2025.11.005_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jcin.2020.09.062","article-title":"Safety and efficacy of transcatheter aortic valve replacement with continuation of vitamin K antagonists or direct oral anticoagulants","volume":"14","author":"Brinkert","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jtha.2025.11.005_bib17","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.11.005_bib18","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","article-title":"Perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2025.11.005_bib19","series-title":"Ned. Internisten ver","year":"2016"},{"key":"10.1016\/j.jtha.2025.11.005_bib20","doi-asserted-by":"crossref","first-page":"766","DOI":"10.4244\/EIJ-D-23-00206","article-title":"Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trial","volume":"19","author":"van Ginkel","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jtha.2025.11.005_bib21","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa2407794","article-title":"Continuation versus interruption of oral anticoagulation during TAVI","volume":"392","author":"van Ginkel","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.11.005_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jtha.2022.11.029","article-title":"DOAC\u2013associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature","volume":"21","author":"Shaw","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.005_bib23","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/jth.15529","article-title":"Thrombin generation assays are versatile tools in blood coagulation analysis: a review of technical features, and applications from research to laboratory routine","volume":"19","author":"Depasse","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.005_bib24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1160\/TH08-03-0141","article-title":"Assessment of thrombin generation II: validation of the calibrated automated thrombogram in platelet-poor plasma in a clinical laboratory","volume":"100","author":"Spronk","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.005_bib25","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.3390\/ijms22052758","article-title":"Assessing plasmin generation in health and disease","volume":"22","author":"Miszta","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2025.11.005_bib26","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1182\/blood.2019004267","article-title":"A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice","volume":"135","author":"Miszta","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.005_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211961","article-title":"Analytical characterization and reference interval of an enzyme-linked immunosorbent assay for active von Willebrand factor","volume":"14","author":"van der Vorm","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.11.005_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.11.005_bib29","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1055\/s-0041-1725190","article-title":"Impact of transcatheter aortic valve implantation on thrombin generation and platelet function","volume":"121","author":"Mourikis","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.005_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejvs.2004.11.001","article-title":"Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease","volume":"29","author":"Cassar","year":"2005","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jtha.2025.11.005_bib31","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1538-7836.2012.04782.x","article-title":"The impact of blood coagulability on atherosclerosis and cardiovascular disease","volume":"10","author":"Loeffen","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.005_bib32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcin.2013.10.016","article-title":"Usefulness of baseline activated clotting time\u2013guided heparin administration in reducing bleeding events during transfemoral transcatheter aortic valve implantation","volume":"7","author":"Bernelli","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jtha.2025.11.005_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2023.07.092","article-title":"Direct oral anticoagulants affect activated clotting time during and bleeding events after percutaneous coronary intervention","volume":"204","author":"Shibahashi","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtha.2025.11.005_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MBC.0000000000000907","article-title":"Effects of rivaroxaban and dabigatran on global hemostasis in patients with atrial fibrillation","volume":"31","author":"Petkovic","year":"2020","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2025.11.005_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11239-020-02126-3","article-title":"Thrombin generation and other hemostatic parameters in patients with atrial fibrillation in use of warfarin or rivaroxaban","volume":"51","author":"Duarte","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2025.11.005_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003553","article-title":"Thrombin generation and atherothrombosis: what does the evidence indicate?","volume":"5","author":"Ten Cate","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtha.2025.11.005_bib37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1182\/blood-2015-05-643403","article-title":"Thrombin generation: biochemical possibilities and clinical reality","volume":"126","author":"Hemker","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.005_bib38","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3390\/jcm9072018","article-title":"Delayed thrombin generation is associated with minor bleedings in venous thromboembolism patients on rivaroxaban: usefulness of calibrated automated thrombography","volume":"9","author":"Zalewski","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2025.11.005_bib39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1749-8090-8-154","article-title":"Preoperative thrombin generation is predictive for the risk of blood loss after cardiac surgery: a research article","volume":"8","author":"Bosch","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.jtha.2025.11.005_bib40","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1055\/a-2521-0923","article-title":"Influence of direct oral anticoagulant levels and thrombin generation on postoperative bleeding [SONAR]: a nested case-control study","volume":"125","author":"Shaw","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.005_bib41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.thromres.2013.12.017","article-title":"Measurement of thrombin generation intra-operatively and its association with bleeding tendency after cardiac surgery","volume":"133","author":"Bosch","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.11.005_bib42","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood-2009-05-222109","article-title":"Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation","volume":"114","author":"Ni Ainle","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.005_bib43","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jamacardio.2024.2454","article-title":"Routine protamine administration for bleeding in transcatheter aortic valve implantation: the ACE-PROTAVI randomized clinical trial","volume":"9","author":"Vriesendorp","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jtha.2025.11.005_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/clc.23936","article-title":"Optimal protamine-to-heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR\u2014a multicenter experience","volume":"46","author":"Al-Kassou","year":"2023","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jtha.2025.11.005_bib45","first-page":"111","article-title":"The contemporary role of protamine in the cardiac catheterization laboratory","volume":"102","author":"Danek","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jtha.2025.11.005_bib46","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jtha.2023.04.005","article-title":"What\u2019s fishy about protamine? Clinical use, adverse reactions, and potential alternatives","volume":"21","author":"Levy","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.005_bib47","article-title":"Routine versus selective protamine administration to reduce bleeding after TAVI: rationale and Design of the POPular ACE TAVI trial","author":"Overduin","year":"2025","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtha.2025.11.005_bib48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1538-7836.2008.03220.x","article-title":"New insights into the molecular mechanisms of the fibrinolytic system","volume":"7","author":"Rijken","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.005_bib49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5603\/CJ.a2020.0143","article-title":"Perioperative D-dimer levels after transcatheter aortic valve replacement: comparison of patients with and without anticoagulant therapy","volume":"28","author":"Tobe","year":"2021","journal-title":"Cardiol J"},{"key":"10.1016\/j.jtha.2025.11.005_bib50","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.11.005_bib51","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.11.005_bib52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jcin.2022.10.010","article-title":"No antithrombotic therapy after transcatheter aortic valve replacement: insight from the OCEAN-TAVI Registry","volume":"16","author":"Kobari","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jtha.2025.11.005_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2023.107358","article-title":"Rationale and design of non-antithrombotic therapy after transcatheter aortic valve implantation (NAPT) trial","volume":"134","author":"Inohara","year":"2023","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jtha.2025.11.005_bib54","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/hae.14825","article-title":"Impact of transcatheter aortic valve implantation on circulating von Willebrand factor in patients with severe aortic stenosis","volume":"29","author":"Varghese","year":"2023","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.11.005_bib55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1505643","article-title":"Von Willebrand factor multimers during transcatheter aortic-valve replacement","volume":"375","author":"Van Belle","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.11.005_bib56","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijcard.2016.07.094","article-title":"TAVI induces an elevation of hemostasis-related biomarkers, which is not causative for post-TAVI thrombocytopenia","volume":"221","author":"Sedaghat","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtha.2025.11.005_bib57","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1093\/eurheartj\/ehad340","article-title":"Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis","volume":"44","author":"Goltstein","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.11.005_bib58","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jcin.2025.01.006","article-title":"Effectiveness of transcatheter aortic valve replacement on acquired von Willebrand syndrome: a prospective cohort study","volume":"18","author":"Rooijakkers","year":"2025","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625008438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625008438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:15:53Z","timestamp":1781939753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625008438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1538783625008438"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.11.005","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of continuation versus interruption of oral anticoagulation during transcatheter aortic valve implantation on hemostasis function","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}